E-LIB Suche - Ergebnisse für: Stegeman, Hanneke

1

Interaction between hypoxia, AKT and HIF-1 signaling in HNS..:

Stegeman, Hanneke ; Span, Paul N ; Peeters, Wenny JM...
Future Science OA. 2 (2016) 1 - p. , 2016

Link: https://doi.org/10.4155/..

2

Hypoxic regulation of the PERK/ATF4/LAMP3‐arm of the unfold..:

Nagelkerke, Anika ; Sweep, Fred C. G. J. ; Stegeman, Hanneke...
Head & Neck. 37 (2014) 6 - p. 896-905 , 2014

Link: https://doi.org/10.1002/..

3

Improving chemoradiation efficacy by PI3-K/AKT inhibition:

Stegeman, Hanneke ; Span, Paul N. ; Kaanders, Johannes H.A.M..
Cancer Treatment Reviews. 40 (2014) 10 - p. 1182-1191 , 2014

Link: https://doi.org/10.1016/..

4

αB-crystallin stimulates VEGF secretion and tumor cell migr..:

van de Schootbrugge, Chantal ; Bussink, Johan ; Span, Paul N...
BMC Cancer. 13 (2013) 1 - p. , 2013

Link: https://doi.org/10.1186/..

5

Predictive value of hypoxia, proliferation and tyrosine kin..:

Stegeman, Hanneke ; Kaanders, Johannes H. ; van der Kogel, Albert J....
Radiotherapy and Oncology. 106 (2013) 3 - p. 383-389 , 2013

Link: https://doi.org/10.1016/..

6

Hypoxia, metabolism, and growth factor signaling in head an..:

Stegeman, Hanneke ; Rademakers, Saskia E. ; Span, Paul N....
Head & Neck. , 2013

Link: https://doi.org/10.1002/..

7

Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibiti..:

Stegeman, Hanneke ; Kaanders, Johannes HAM ; Verheijen, Marieke MG...
Molecular Cancer. 12 (2013) 1 - p. 133 , 2013

Link: https://doi.org/10.1186/..

8

Dasatinib Inhibits DNA Repair after Radiotherapy Specifical..:

Stegeman, Hanneke ; Span, Paul N. ; Rijken, Paul F.J.W....
Translational Oncology. 6 (2013) 4 - p. 413-419 , 2013

Link: https://doi.org/10.1593/..

9

Low Phosphorylated AKT Expression in Laryngeal Cancer: Indi..:

Nijkamp, Monique M. ; Span, Paul N. ; Stegeman, Hanneke...
International Journal of Radiation Oncology*Biology*Physics. 87 (2013) 2 - p. 349-355 , 2013

Link: https://doi.org/10.1016/..

10

Hypoxia Regulation of Phosphokinases and the Prognostic Val..:

Wennemers, Marloes ; Stegeman, Hanneke ; Bussink, Johan...
The International Journal of Biological Markers. 28 (2013) 2 - p. 151-160 , 2013

Link: https://doi.org/10.5301/..

11

111In-cetuximab-F(ab')2 SPECT imaging for quantification of..:

van Dijk, Laura K. ; Hoeben, Bianca A.W. ; Stegeman, Hanneke...
Radiotherapy and Oncology. 108 (2013) 3 - p. 484-488 , 2013

Link: https://doi.org/10.1016/..

12

Activation of AKT by hypoxia: a potential target for hypoxi..:

Stegeman, Hanneke ; Kaanders, Johannes H ; Wheeler, Deric L...
BMC Cancer. 12 (2012) 1 - p. , 2012

Link: https://doi.org/10.1186/..

13

Neural progenitor cells as models for high-throughput scree..:

Breier, Joseph M. ; Gassmann, Kathrin ; Kayser, Reinier...
Neurotoxicology and Teratology. 32 (2010) 1 - p. 4-15 , 2010

Link: https://doi.org/10.1016/..

14

Development of an in vitro stem cell assay to test developm..:

De Groot, Didima ; Stegeman, Hanneke ; Bhola, Akash...
Toxicology Letters. 180 (2008) - p. S99-S100 , 2008

Link: https://doi.org/10.1016/..

15

Stem cell assay for quantitative in vitro developmental neu..:

de Groot, Didima ; Schulpen, Sjors ; Stegeman, Hanneke...
Reproductive Toxicology. 26 (2008) 1 - p. 62 , 2008

Link: https://doi.org/10.1016/..